362 reports of this reaction
2.2% of all TIMOLOL MALEATE reports
#6 most reported adverse reaction
DIZZINESS is the #6 most commonly reported adverse reaction for TIMOLOL MALEATE, manufactured by Bausch & Lomb Incorporated. There are 362 FDA adverse event reports linking TIMOLOL MALEATE to DIZZINESS. This represents approximately 2.2% of all 16,822 adverse event reports for this drug.
Patients taking TIMOLOL MALEATE who experience dizziness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIZZINESS is a less commonly reported adverse event for TIMOLOL MALEATE, but still significant enough to appear in the safety profile.
In addition to dizziness, the following adverse reactions have been reported for TIMOLOL MALEATE:
The following drugs have also been linked to dizziness in FDA adverse event reports:
DIZZINESS has been reported as an adverse event in 362 FDA reports for TIMOLOL MALEATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIZZINESS accounts for approximately 2.2% of all adverse event reports for TIMOLOL MALEATE, making it a notable side effect.
If you experience dizziness while taking TIMOLOL MALEATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.